Today: 29 April 2026
Browse Category

NYSE:BAX 10 August 2025 - 30 October 2025

Baxter Stock Plummets 15% After Mixed Q3 Earnings – What Investors Should Know

Baxter Stock Plummets 15% After Mixed Q3 Earnings – What Investors Should Know

Baxter shares fell about 16% to $19 on Oct. 30 after cutting its 2025 outlook and missing Q3 sales forecasts. Q3 revenue rose 5% to $2.84 billion, but sales missed estimates; adjusted EPS of $0.69 beat expectations. The company halted Novum IQ infusion pump shipments after two patient deaths and reported hurricane-related supply disruptions. Andrew Hider became CEO in July.
30 October 2025
Breakthrough Cures, FDA Shake-Ups & Pharma Mega‑Deals: Global Health News Roundup (Aug 9–10, 2025)

Breakthrough Cures, FDA Shake-Ups & Pharma Mega‑Deals: Global Health News Roundup (Aug 9–10, 2025)

China researchers reported a hydrogel “smart” wound dressing that closed 90% of diabetic ulcers in mice within 12 days by delivering microRNA vesicles. The FDA approved Boehringer Ingelheim’s Hernexeos for advanced non-squamous NSCLC, with 75% of treated patients seeing tumors shrink or disappear. U.S. IV saline shortages ended as Baxter’s North Carolina plant resumed production after hurricane damage.

Stock Market Today

  • Avantis International Equity ETF (AVDE) Sees $188M Inflows, Shell, HSBC, Novartis Impacted
    April 29, 2026, 11:45 AM EDT. The Avantis International Equity ETF (AVDE) experienced a significant $188.1 million inflow, marking a 2.2% rise in outstanding units week over week. Key underlying holdings include Shell plc (SHEL), which dipped 0.9%, HSBC Holdings plc (HSBC) up 0.7%, and Novartis (NVS) gaining 0.2%. AVDE's share price stands near its 52-week high at $76.43, close to the peak of $76.79, with a 52-week low at $58.56. The ETF creation process, involving issuance of new units, drives the purchase of underlying assets, affecting component stocks. Monitoring changes in ETF units offers insight into market demand and potential stock movements within funds.

Latest article

Applied Materials (AMAT) Faces Fresh China Shock After U.S. Targets Hua Hong Shipments

Applied Materials (AMAT) Faces Fresh China Shock After U.S. Targets Hua Hong Shipments

29 April 2026
The U.S. Commerce Department ordered Applied Materials, Lam Research, and KLA to halt some chip-tool shipments to China’s Hua Hong, Reuters reported. The move targets shipments linked to facilities believed capable of advanced chip production. Applied reported $2.10 billion in China revenue last quarter, or 30% of its total. Shares in Applied, Lam, and KLA traded lower after the news.
Cognizant Stock Drops As Weak Revenue Outlook Overshadows $600 Million AI Deal

Cognizant Stock Drops As Weak Revenue Outlook Overshadows $600 Million AI Deal

29 April 2026
Cognizant forecast second-quarter revenue below analyst estimates and announced Project Leap, a cost-cutting program focused on workforce reductions. Shares fell $1.67 to $53.45. The company reported first-quarter revenue of $5.41 billion, up 5.8%, and agreed to acquire AI infrastructure firm Astreya for about $600 million.
ON Semiconductor Stock Jumps as Geely and NIO Deals Put 900V EV Chips in Focus

ON Semiconductor Stock Jumps as Geely and NIO Deals Put 900V EV Chips in Focus

29 April 2026
ON Semiconductor shares jumped 8% Wednesday after announcing expanded silicon carbide chip deals with Geely Auto Group and NIO Inc., both focused on 900-volt electric vehicle platforms. The company’s market value reached about $41.2 billion ahead of first-quarter results due May 4. Investors are watching whether new auto-chip wins can offset uneven demand.
Go toTop